drugset / Trial / NCT02386800
CINC424A2X01B Rollover Protocol
NaSingle-groupOpen-labelTreatment
Summary
This is a long term safety study for patients that have been treated with either ruxolitinib or a combination of ruxolitinib with panobinostat, on a Novartis or Incyte sponsored study, who have been judged by the study Investigator to benefit from ongoing treatment.
Timeline
- Start
- 2015-03-05
- Primary completion
- 2027-09-16
- Completion
- 2032-04-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Panobinostat | Small molecule | — | Oral |
| Subject | Ruxolitinib | Small molecule | — | Oral |